Navigation Links
ABT is the Only Source for Kelo-cote(R) Advanced Formula Scar Gel
Date:6/25/2008

CLEARWATER, Fla., June 25 /PRNewswire/ -- Kelo-cote(R) advanced formula scar gel is a unique patented silicone formula using cross-link technology and has become the gold standard for scar treatment and abnormal scar prevention. The patented silicone formula in Kelo-cote(R) advanced formula scar gel is ONLY available from Advanced Bio-Technologies, Inc.(ABT).

Kelo-cote(R) is no longer available under the Dermatix label. Doctors and customers should not be misled by competitors' claims they offer the same product. Specifically, Valeant Pharmaceutical's claim that Dermatix and Dermatix Ultra contain the same formula or an improvement of Kelo-cote(R) advanced formula scar gel is FALSE. Dermatix and Dermatix Ultra are not manufactured by ABT and neither contains the Kelo-cote(R) formula.

Prior to July 2007, Kelo-cote(R) was available under the Dermatix label, but Valeant's license to market Kelo-cote(R) was terminated. Doctors should be aware that clinical data published under the brand name Dermatix prior to July 2007 was conducted using the current Kelo-cote(R) formula, but Kelo-cote(R) is no longer available under the Dermatix label.

To ABT's knowledge and belief, neither Dermatix nor Dermatix Ultra have clinical evidence supporting its efficacy. Kelo-cote(R) advanced formula scar gel has the ONLY clinically proven patented self-drying silicone formulation that creates a flexible, breathable silicone gel sheet. This is the reason Kelo-cote(R) advanced formula scar gel from ABT is the gold standard for scar treatment and prevention.

Kelo-cote(R) is manufactured by Advanced Bio-Technologies, Inc. headquartered in Clearwater, FL.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Lisa Massaad https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=67863


'/>"/>
SOURCE Advanced Bio-Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Decision Resources, Inc. Acquires Manhattan Research
2. Energetiqs Laser-Driven Light Source Technology Enables Continuous Spectrum Light Sources, from Visible to Deep Ultraviolet
3. New discoveries, new labs highlight international Canadian Light Source meeting
4. Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs
5. MAP Pharmaceuticals Appoints Marco Rosa Vice President of Human Resources
6. Engineers demonstrate first room-temperature semiconductor source of coherent Terahertz radiation
7. Eklin Announces Acquisition of Ultrasource, Inc.
8. Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources
9. Global Blood Resources On-Line Calculator Reveals Wasted Blood Costs by Blood Salvage Machines During Heart Surgery to be in the Billions
10. /C O R R E C T I O N from Source -- Resverlogix Corp./
11. ETEX Announces Supply Agreement with AlloSource
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , ... October 12, 2017 , ... ... today announced the three Winners and six Finalists of the 2017 Blavatnik Regional ... by the Blavatnik Family Foundation and administered by the New York Academy of ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... Rosalind™, the first-ever genomics analysis platform specifically designed for life science researchers ... honor of pioneering researcher Rosalind Franklin, who made a major contribution to ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... pathology, announced today it will be hosting a Webinar titled, “Pathology is going ... Pathology Associates , on digital pathology adoption best practices and how Proscia improves ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
Breaking Biology Technology:
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):